Abrdn Life Sciences Investors (HQL) Provides Attractive Value Amid Declining Interest Rates

Abrdn Life Sciences Investors (HQL) offers a diverse exposure to healthcare and life science businesses in the US, aiming for long-term capital appreciation while prioritizing returns over risk. Despite concerns about the fund's performance, it remains an attractive option as long as interest rates decline, potentially benefiting from a lower cost of capital.